Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 28, 2019
Stochastic Counterfactual Risk Analysis for the Vulnerability Assessment of Cyber-Physical Attacks on Electricity Distribution Infrastructure NetworksEdward J Oughton, Daniel Ralph, Raghav Pant, et al.Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Epitope Mapping via Phage Display from Single-Gene LibrariesViola Fühner, Philip Alexander Heine, Kilian Johannes Carl Zilkens, et al.Cells|June 10, 2023
Generation of Chimeric Antigen Receptors against Tetraspanin 7Tom Pieper, Kristian Daniel Ralph Roth, Viktor Glaser, et al.Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Selection via Phage Display in Microtiter PlatesStephan Steinke, Kristian Daniel Ralph Roth, Maximilian Ruschig, et al.Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.Pageof 2